Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | RARA | P10276 | 2/20 | 0.32 |
| ▸ | RARB | P10826 | 2/20 | 0.32 |
| ▸ | RARG | P13631 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | TNFRSF1A | P19438 | 2/20 | 0.31 |
| ▸ | WDR5 | P61964 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14026086 | 0.77 | PTGS2 (0.44) | ALDH1A1LMNATP53CYP3A4HPGD | |
| SCHEMBL13705717 | 0.67 | RXRA (0.50) | ALDH1A1RARARARBRARGLMNA | |
| SCHEMBL12585362 | 0.66 | TNFRSF1A (0.34) | ALDH1A1RARGTNFRSF1A | |
| SCHEMBL14045908 | 0.66 | TNFRSF1A (0.34) | ALDH1A1RARGTNFRSF1A | |
| SCHEMBL13889244 | 0.64 | TNFRSF1A (0.37) | RARARARBRARGTNFRSF1A | |
| SCHEMBL13889330 | 0.64 | TNFRSF1A (0.37) | RARARARBRARGTNFRSF1A | |
| SCHEMBL8302162 | 0.63 | TNFRSF1A (0.47) | RARARARBRARGTNFRSF1AWDR5 | |
| SCHEMBL8308995 | 0.62 | TNFRSF1A (0.43) | ALDH1A1GAARARARARBRARG | |
| SCHEMBL4457970 | 0.61 | PTGS2 (0.44) | ALDH1A1RARGLMNATP53CYP3A4 | |
| SCHEMBL6248683 | 0.60 | PTGS2 (0.45) | ALDH1A1LMNATP53CYP3A4HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080242893-A1 | Process for Preparing Optically Active Diphosphanes | BASF AKTIENGESELLSCHAFT (DE) | 2008-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080242893-A1 | Process for Preparing Optically Active Diphosphanes | PHOSPHO1, DCTPP1, DCPS | ALDH1A1 899/4885GAA 1561/4885RARA 967/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.